TY - JOUR
T1 - Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
AU - Thompson, George R
AU - Le, Thuy
AU - Chindamporn, Ariya
AU - Kauffman, Carol A
AU - Alastruey-Izquierdo, Ana
AU - Ampel, Neil M
AU - Andes, David R
AU - Armstrong-James, Darius
AU - Ayanlowo, Olusola
AU - Baddley, John W
AU - Barker, Bridget M
AU - Lopes Bezerra, Leila
AU - Buitrago, Maria J
AU - Chamani-Tabriz, Leili
AU - Chan, Jasper F W
AU - Chayakulkeeree, Methee
AU - Cornely, Oliver A
AU - Cunwei, Cao
AU - Gangneux, Jean-Pierre
AU - Govender, Nelesh P
AU - Hagen, Ferry
AU - Hedayati, Mohammad T
AU - Hohl, Tobias M
AU - Jouvion, Grégory
AU - Kenyon, Chris
AU - Kibbler, Christopher C
AU - Klimko, Nikolai
AU - Kong, David C M
AU - Krause, Robert
AU - Lee Lee, Low
AU - Meintjes, Graeme
AU - Miceli, Marisa H
AU - Rath, Peter-Michael
AU - Spec, Andrej
AU - Queiroz-Telles, Flavio
AU - Variava, Ebrahim
AU - Verweij, Paul E
AU - Schwartz, Ilan S
AU - Pasqualotto, Alessandro C
N1 - NPP; NOOA; CHECK; Copyright © 2021 Elsevier Ltd. All rights reserved.
PY - 2021
Y1 - 2021
N2 - The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the "One World, One Guideline" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.
AB - The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the "One World, One Guideline" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.
U2 - 10.1016/S1473-3099(21)00191-2
DO - 10.1016/S1473-3099(21)00191-2
M3 - A1: Web of Science-article
C2 - 34364529
SN - 1473-3099
VL - 21
SP - e364-e374
JO - Lancet Infectious Diseases
JF - Lancet Infectious Diseases
IS - 12
ER -